Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03303872
Other study ID # 1-2017-0008
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 31, 2017
Est. completion date December 31, 2022

Study information

Verified date June 2018
Source Yonsei University
Contact Boyoung Joung, M.D., Ph.D.
Phone 82-10-8025-0424
Email CBY6908@yuhs.ac
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

This study is prospective Cohort study which was performed in multicenter (General Hospital) in Korea. Inclusion criteria is patients post pacemaker implantation. The purpose is to investigate the occurrence of device detected subclinical atrial fibrillation (atrial high rate episode) in patients post pacemaker implantation and assess long term clinical results.


Recruitment information / eligibility

Status Recruiting
Enrollment 900
Est. completion date December 31, 2022
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Age: 18-80 years

- Patients eligible for the indications for permanent pacemaker implantation in accordance with 2016 revised Korean indication guideline on cardiac pacemaker implantation

- Estimated percentage of atrial pacing >40% under sinus rhythm (LR=60bpm, close hysteresis and rest rate)

- Estimated percentage of ventricular pacing >40% under sinus rhythm (LR=40bpm, DDD pacing, close hysteresis and rest rate)

- Patients who are willing to sign the informed consent.

- Patients who are willing to receive the implantation and post-operative follow-up.

Exclusion Criteria:

- Persistent or permanent AF

- Severe hepatic and renal insufficiency (AST or ALT = three times of normal upper limit; SCr > 3.5 mg/dl or Ccr < 30ml/min)

- Thyroid gland dysfunction

- Pregnancy

- Malignant tumor

- Severe organic heart disease (such as moderate to severe mitral regurgitation, dilated cardiomyopathy, hypertrophic cardiomyopathy, severe heart valve disease)

- Life expectancy < 12 months

- Patients unable or unwilling to cooperate in the study procedures.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Korea, Republic of Division of Cardiology Severance Cardiovascular Hospital, Yonsei University College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Occurrence of subclinical atrial fibrillation (atrial high rate episode) 3 months after pacemaker implantation
Primary Occurrence of subclinical atrial fibrillation (atrial high rate episode) 6 months after pacemaker implantation
Primary Occurrence of subclinical atrial fibrillation (atrial high rate episode) Occurrence of subclinical atrial fibrillation (atrial high rate episode) during 36 months (3 years) post pacemaker implant every 1 year upto 3 years after pacemaker implantation
Primary Occurrence of stroke Stroke based on device detected subclinical atrial fibrillation episodes 3 months after pacemaker implantation
Primary Occurrence of stroke Stroke based on device detected subclinical atrial fibrillation episodes 6 months after pacemaker implantation
Primary Occurrence of stroke Stroke based on device detected subclinical atrial fibrillation episodes every 1 year upto 3 years after pacemaker implantation